Aventura Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$571K Sell
9,911
-3,230
-25% -$185K 0.18% 88
2026
Q1
$797K Sell
13,141
-155
-1% -$9.04K 0.29% 63
2025
Q4
$717K Sell
13,296
-1,587
-11% -$76.3K 0.26% 73
2025
Q3
$671K Sell
14,883
-3,195
-18% -$149K 0.25% 76
2025
Q2
$837K Sell
18,078
-1,896
-9% -$93.1K 0.36% 57
2025
Q1
$1.22M Buy
19,974
+716
+4% +$41.7K 0.64% 32
2024
Q4
$1.09M Buy
+19,258
New +$1.08M 0.59% 36

Other funds holding BMY

Aventura Private Wealth's BMY Position: Q2 2026 in Review

Aventura Private Wealth reduced its Bristol-Myers Squibb (BMY) stake by 25% in Q2 2026, selling an estimated $185K and leaving 9,911 shares worth $571K. The position accounts for 0.18% of the portfolio, ranked #88.

Aventura Private Wealth first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.22M in Q1 2025. 1,157 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Aventura Private Wealth held 9,911 shares of Bristol-Myers Squibb worth $571K as of Q2 2026.
  • Aventura Private Wealth sold 3,230 Bristol-Myers Squibb shares in Q2 2026, an estimated $185K.
  • Bristol-Myers Squibb made up 0.18% of Aventura Private Wealth's portfolio in Q2 2026, its #88 holding.
  • Aventura Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Aventura Private Wealth's Bristol-Myers Squibb position peaked at $1.22M in Q1 2025.
  • 1,157 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.